PDM-35: Difference between revisions
CSV import |
CSV import |
||
| Line 39: | Line 39: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 21:30, 17 March 2025
PDM-35 is a protein that in humans is encoded by the PDM-35 gene. The protein encoded by this gene is a member of the protein family that includes protein kinases, which are enzymes that add a phosphate group to other proteins in order to change their activity.
Function[edit]
The exact function of PDM-35 is not fully understood. However, it is known to be involved in several important biological processes. These include cell division, cell growth, and cell differentiation, which is the process by which a cell changes from one type to another.
Clinical significance[edit]
Mutations in the PDM-35 gene have been associated with a number of diseases. These include cancer, neurodegenerative diseases, and cardiovascular diseases. In particular, PDM-35 has been implicated in the development of breast cancer and prostate cancer.
Pharmacology[edit]
Several drugs are currently being developed that target PDM-35. These drugs are designed to inhibit the activity of PDM-35, thereby preventing the growth and spread of cancer cells.
See also[edit]
- Protein kinase
- Cell division
- Cell growth
- Cell differentiation
- Cancer
- Neurodegenerative diseases
- Cardiovascular diseases
- Breast cancer
- Prostate cancer
References[edit]
<references />
